Immunotherapy trial eligibility criteria exclude majority of metastatic melanoma patients – medwireNews
|
Immunotherapy trial eligibility criteria exclude majority of metastatic melanoma patients
medwireNews medwireNews: Over half of patients with metastatic melanoma do not meet eligibility criteria for participation in phase III clinical trials of immunotherapy agents, highlight study findings. Just 45% of 276 unselected patients recorded in the … |
